Maintenance Chemoimmunotherapy of Nonlymphoblastic Acute Leukemias
A trial of maintenance chemotherapy of nonlymphoblastic acute leukemia led to a comparison of two groups of patients in complete remission. Group 1 (14 patients) received only monthly reinduction chemotherapy. Group 2 (17 patients) received identical chemotherapy together with weekly immunotherapy combining BCG and irradiated leukemic cells. While the duration of the first complete remission was unmodified, the overall survival time and, above all, survival after the first relapse were prolonged in group 2 chemoimmunotherapy. These results were all the more marked when a homogeneous group of patients having received the same induction chemotherapy were considered.
KeywordsComplete Remission Acute Leukemia Acute Myelogenous Leukaemia Maintenance Chemotherapy Allogeneic Cell
Unable to display preview. Download preview PDF.
- 5.Galton DA (1979) Can remission duration be prolonged in acute myeloid leukaemia? Recent Results Cancer Res 69:JJ-62Google Scholar
- 8.Holland JF, Bekesi JG, Cuttner J (1978) Immunotherapy of human cancer. Raven Press, New York, pp 237–244Google Scholar
- 12.Schwartz D, Flamant R, Lellouch J (1970) L’essai therapeutique chez l’homme. Flammarion, ParisGoogle Scholar